NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
23/10/2024
Voltar para busca
Dado oficial do USPTO
THERANOVA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
23/10/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42
Data de depósito
23/06/2016
Data de registro
06/03/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/10/2024
Última transação
23/10/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
31/12/2005
Primeiro uso no comércio
31/12/2005
Código do desenho
4
Tipo de titular
16
Localização do titular
San Francisco, CA, US
Examinador
MULLEN, MARK
Localização atual
Historical data usage
Titulares e representantes
Titulares
Theranova LLC
Representantes
Donald A. Thompson THOMPSON & CO.
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business consulting services in the field of medical devices; Business consulting and management in the field of clinical trials concerning medical devicesproviding information management services; Business consulting services in the field of regulatory approvals concerning medical devices; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Business consulting services in the field of regulatory submissions concerning medical devices; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for medical device approval; Business consulting and management in the field of clinical trials concerning medical devicesproviding information management services; Business consulting services in the field of quality system information management concerning medical devices; Regulatory submission managementassisting others in preparing and filing applications for medical devices with governmental regulatory bodies; in each caseexcept in connection with dialysis
Classe 42
Consulting services in the field of medical device product development; Consulting servicesproduct testingproduct safety testing and product quality testing consultation in the field of experimental tests concerning medical devices; Consulting services regarding the conducting of clinical trials for others relating to medical devices in the field of physical paincardiovascular diseasediabetesosteoporosisdementiaincontinenceoveractive bladdervascular accessbody fluid drainageenteral feeding and monitoring; New product designengineeringresearchdevelopment services for others in the field of medical devices; in each caseexcept in the field of dialysis
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
23/10/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23/10/2024
E815
TEAS SECTION 8 & 15 RECEIVED
29/04/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/11/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/11/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
06/03/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
31/01/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
30/01/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
30/01/2018
DPCC
DIVISIONAL PROCESSING COMPLETE
30/01/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
29/01/2018
IUAF
USE AMENDMENT FILED
17/01/2018
DRRR
DIVISIONAL REQUEST RECEIVED
17/01/2018
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
17/01/2018
EISU
TEAS STATEMENT OF USE RECEIVED
17/01/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/08/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/06/2017
PUBO
PUBLISHED FOR OPPOSITION
06/06/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/05/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/04/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/03/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/03/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/02/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/02/2017
DOCK
ASSIGNED TO EXAMINER
09/01/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/10/2016
GNRT
NON-FINAL ACTION E-MAILED
06/10/2016
CNRT
NON-FINAL ACTION WRITTEN
06/10/2016
DOCK
ASSIGNED TO EXAMINER
29/09/2016
MPMK
NOTICE OF PSEUDO MARK E-MAILED
30/06/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/06/2016
NWAP
NEW APPLICATION ENTERED
27/06/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace THERANOVA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.